Page last updated: 2024-10-16

anthranilic acid and Alzheimer Disease

anthranilic acid has been researched along with Alzheimer Disease in 3 studies

anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
"The kynurenine pathway (KP) is a major route of tryptophan metabolism."1.36Kynurenine and its metabolites in Alzheimer's disease patients. ( Bien, B; Gulaj, E; Pawlak, D; Pawlak, K, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fathi, M1
Vakili, K1
Yaghoobpoor, S1
Tavasol, A1
Jazi, K1
Hajibeygi, R1
Shool, S1
Sodeifian, F1
Klegeris, A1
McElhinney, A1
Tavirani, MR1
Sayehmiri, F1
Paul, A1
Nadimpally, KC1
Mondal, T1
Thalluri, K1
Mandal, B1
Gulaj, E1
Pawlak, K1
Bien, B1
Pawlak, D1

Reviews

1 review available for anthranilic acid and Alzheimer Disease

ArticleYear
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Frontiers in immunology, 2022, Volume: 13

    Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleac

2022

Other Studies

2 other studies available for anthranilic acid and Alzheimer Disease

ArticleYear
Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
    Chemical communications (Cambridge, England), 2015, Feb-11, Volume: 51, Issue:12

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Circular Dichroism; Humans; Microscopy, Electron, Transmis

2015
Kynurenine and its metabolites in Alzheimer's disease patients.
    Advances in medical sciences, 2010, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Chromatography, High Pressure Liquid; Female; Humans; Ky

2010